Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Final Thoughts on Improving Access and Care
Panelists discuss how collaboration, innovation, and stigma reduction are key to transforming schizophrenia care.
EP: 1.Clinical and Economic Burden of Schizophrenia
EP: 2.Symptoms Associated with Schizophrenia
EP: 3.Risk Factors for Schizophrenia
EP: 4.Challenges of Early and Accurate Diagnosis in Schizophrenia
EP: 5.Exploring Schizophrenia Progression and Its Impact on Quality of Life
EP: 6.Consequences of Relapse in Schizophrenia Care
EP: 7.Addressing Social Determinants of Health and Unmet Needs in Schizophrenia
EP: 8.Current Treatment Guidelines for Schizophrenia
EP: 9.First- and Second-Generation Antipsychotic Therapies and Treatment Sequencing
EP: 10.Switching Therapies, Managing Adverse Effects, and Adherence Challenges
EP: 11.Xanomeline/Trospium Mechanism of Action, Efficacy, and Safety
EP: 12.Use of Xanomeline/Trospium in Clinical Practice
EP: 13.Comparing Safety Profiles and Health Care Costs
EP: 14.Emerging Therapies in Schizophrenia
EP: 15.Addressing Access Barriers and Formulary Restrictions
Now Viewing
EP: 16.Final Thoughts on Improving Access and Care
Panelists discuss how advancing schizophrenia care requires alignment among clinicians, policymakers, and industry to ensure consistent access to innovation.
Panelists discuss how integrating novel treatments with psychosocial support can improve adherence and empower patients toward recovery.
Panelists discuss how sustained efforts to reduce stigma and expand early intervention programs remain vital to achieving equitable, compassionate care.
Related Videos
Related Content
